HIGHLIGHTS
- who: Lung Adenocarcinoma and colleagues from the School of Chinese Medicine, School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China have published the research work: Prognostic Signature, Immune Features, and Therapeutic Responses of a Novel Ubiquitination-Related Gene Signature in Lung Adenocarcinoma, in the Journal: Journal of Oncology 1888 of 16/08/2022
- what: In this study a total of 71 ubiquitination-related DEGs were identified. The authors conducted an analysis of the TCGA and GEO datasets to choose various UbRGs that were distinctly related to the outcomes of LUAD . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.